These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38057203)

  • 81. Positive axillary sentinel lymph node: is axillary dissection always necessary?
    Galimberti V; Chifu C; Rodriguez Perez S; Veronesi P; Intra M; Botteri E; Mastropasqua M; Colleoni M; Luini A; Veronesi U
    Breast; 2011 Oct; 20 Suppl 3():S96-8. PubMed ID: 22015302
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Sentinel node biopsy in breast cancer: techniques and indications].
    Haid A; Knauer M; Köberle-Wührer R; Wenzl E
    Wien Klin Wochenschr; 2005 Feb; 117(4):121-8. PubMed ID: 15847190
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
    Wernicke AG; Goodman RL; Turner BC; Komarnicky LT; Curran WJ; Christos PJ; Khan I; Vandris K; Parashar B; Nori D; Chao KS
    Breast Cancer Res Treat; 2011 Feb; 125(3):893-902. PubMed ID: 20853176
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer.
    Straver ME; Meijnen P; van Tienhoven G; van de Velde CJ; Mansel RE; Bogaerts J; Demonty G; Duez N; Cataliotti L; Klinkenbijl J; Westenberg HA; van der Mijle H; Hurkmans C; Rutgers EJ
    J Clin Oncol; 2010 Feb; 28(5):731-7. PubMed ID: 20038733
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Conservative axillary surgery in breast cancer patients undergoing mastectomy: long-term results.
    Cowher MS; Grobmyer SR; Lyons J; O'Rourke C; Baynes D; Crowe JP
    J Am Coll Surg; 2014 Apr; 218(4):819-24. PubMed ID: 24655877
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
    Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
    Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Incorporating Lymphovenous Anastomosis in Clinically Node-Positive Women Receiving Neoadjuvant Chemotherapy: A Shared Decision-Making Model and Nuanced Approached to the Axilla.
    Lustig DB; Temple-Oberle C; Bouchard-Fortier A; Quan ML
    Curr Oncol; 2023 Apr; 30(4):4041-4051. PubMed ID: 37185419
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer.
    Huxley N; Jones-Hughes T; Coelho H; Snowsill T; Cooper C; Meng Y; Hyde C; Mújica-Mota R
    Health Technol Assess; 2015 Jan; 19(2):v-xxv, 1-215. PubMed ID: 25586547
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 92. Axillary node interventions in breast cancer: a systematic review.
    Rao R; Euhus D; Mayo HG; Balch C
    JAMA; 2013 Oct; 310(13):1385-94. PubMed ID: 24084924
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Contemporary approaches to the axilla in breast cancer.
    Thompson JL; Wright GP
    Am J Surg; 2023 Mar; 225(3):583-587. PubMed ID: 36522219
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Extranodal extension of axillary metastasis of invasive breast carcinoma as a possible predictor for the total number of positive lymph nodes.
    Palamba HW; Rombouts MC; Ruers TJ; Klinkenbijl JH; Wobbes T
    Eur J Surg Oncol; 2001 Dec; 27(8):719-22. PubMed ID: 11735167
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Breast cancer hormone receptor negativity, triple-negative type, mastectomy and not receiving adjuvant radiotherapy were associated with axillary recurrence after sentinel lymph node biopsy.
    Sekine C; Nakano S; Mibu A; Otsuka M; Oinuma T; Takeyama H
    Asian J Surg; 2020 Jan; 43(1):148-153. PubMed ID: 31153730
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hypofractionation for Regional Nodal Irradiation in Breast Cancer: Best of Both the Worlds.
    Yadav BS; Dey T
    Clin Breast Cancer; 2024 Jul; 24(5):399-410. PubMed ID: 38614852
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Toxicity Evaluation of Dose-Escalation in Hypofractionated Regional Nodal Irradiation for Breast Cancer: A Retrospective Study.
    Kim E; Yoo JS; Kim YJ; Joo J; Oh ES; Chung Y; Chung SH; Kim TH
    Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):823-834. PubMed ID: 38631540
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Advances in regional nodal management of early-stage breast cancer.
    Bi Z; Wang Y
    Chin J Cancer Res; 2024 Apr; 36(2):215-225. PubMed ID: 38751438
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.